Re: Androgen deprivation therapy and radiotherapy in intermediate risk prostate cancer: A randomized phase III trial

dc.contributor.authorGuler, Ozan Cem
dc.contributor.authorOnal, Cem
dc.contributor.orcID0000-0002-2742-9021en_US
dc.contributor.pubmedID35282967en_US
dc.contributor.researcherIDD-5195-2014en_US
dc.date.accessioned2022-12-15T12:28:01Z
dc.date.available2022-12-15T12:28:01Z
dc.date.issued2022
dc.identifier.endpage165en_US
dc.identifier.issn0959-8049en_US
dc.identifier.scopus2-s2.0-85129357741en_US
dc.identifier.startpage164en_US
dc.identifier.urihttp://hdl.handle.net/11727/8307
dc.identifier.volume167en_US
dc.identifier.wos000807170000007en_US
dc.language.isoengen_US
dc.relation.isversionof10.1016/j.ejca.2022.01.041en_US
dc.relation.journalEUROPEAN JOURNAL OF CANCERen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectRADIATIONen_US
dc.titleRe: Androgen deprivation therapy and radiotherapy in intermediate risk prostate cancer: A randomized phase III trialen_US
dc.typeletteren_US

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: